MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on September 18, 2007; DOI: 10.1124/mol.107.039792


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.039792v1
72/6/1545    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aires, V.
Right arrow Articles by Khan, N. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aires, V.
Right arrow Articles by Khan, N. A.


Received for publication July 11, 2007.
Revised September 14, 2007.
Accepted for publication September 17, 2007.

DHA INDUCES INCREASES IN [Ca2+]i IP3 PRODUCTION AND ACTIVATES SELECTIVELY PKC{gamma} AND {delta} VIA PHOSPHATIDYLSERINE BINDING SITE : IMPLICATION IN APOPTOSIS IN U937 CELLS

Virginie Aires 1, Aziz Hichami 1, Rodolphe Filomenko 2, Aude Ple 1, Cedric Rebe 3, Ali Bettaieb 3, Naim Akhtar Khan 1*

1 Universite de Bourgogne 2 INSERM U 517 3 INSERM U517

* Address correspondence to: E-mail: naim.khan{at}u-bourgogne.fr

Abstract

We investigated, in monocytic leukemia U937 cells, the effects of docosahexaenoic acid (DHA, 22:6 n-3) on calcium signaling and determined the implication of phospholipase C (PLC) and protein kinase C (PKC) in this pathway. DHA induced dose-dependent increases in [Ca2+]i which were contributed by intracellular pool, via the production of IP3 and store-operated Ca2+ (SOC) influx, via opening of Ca2+ release-activated Ca2+ (CRAC) channels. Chemical inhibition of PLC, and PKC{gamma} and PKC{delta}, but not of PKC{beta}I/II, PKC{alpha} or {beta}I, significantly diminished DHA-induced increases in [Ca2+]i. In vitro PKC assays revealed that DHA induced a ~2-fold increase in PKC{gamma} and {delta} activities which were temporally correlated with the DHA-induced increases in [Ca2+]i. In cell-free assays, DHA, but not other structural analogues of fatty acids, activated these PKC isoforms. Competition experiments revealed that DHA-induced activation of both the PKCs was dose-dependently inhibited by phosphatidylserine (PS). Furthermore, DHA induced apoptosis via reactive oxygen species (ROS) production, followed by caspase-3 activation. Chemical inhibition of PKC{gamma}/{delta} and of SOC/CRAC channels significantly attenuated both DHA-stimulated ROS production and caspase-3 activity. Our study suggests that DHA-induced activation of PLC/IP3 pathway and activation of PKC{gamma}/{delta} via its action on PS binding site, may be involved in apoptosis in U937 cells.


Key words: Protein Kinase C, Oxidative stress/antioxidants, Mechanisms of cell killing/apoptosis





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics